Pfizer (PFE) Treasury Shares (2009 - 2026)

Pfizer (PFE) has 18 years of Treasury Shares data on file, last reported at $115.2 billion in Q1 2026.

• Treasury Shares for Q1 2026 came in at $115.2 billion, changed 0.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $115.2 billion (changed 0.16% YoY), and the FY2025 annual result was $115.0 billion, changed 0.22% from the prior year.
• Treasury Shares held at $115.2 billion in Q1 2026 per PFE's latest filing, from $115.0 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $3.9 billion in Q1 2026 and troughed at $39.0 million in Q2 2022.
• A 5-year average of $3.7 billion and a median of $3.9 billion in 2024 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2026: Treasury Shares increased 2.34% in 2022, then grew 0.16% in 2026.
• A 5-year view of Treasury Shares shows it stood at $114.0 billion in 2022, then gained by 0.45% to $114.5 billion in 2023, then gained by 0.24% to $114.8 billion in 2024, then grew by 0.22% to $115.0 billion in 2025, then climbed by 0.15% to $115.2 billion in 2026.
• Business Quant data shows PFE's Treasury Shares at $115.2 billion in Q1 2026, $115.0 billion in Q4 2025, and $115.0 billion in Q3 2025.